Kaya A, Kaya S, Balkan I, Alkan S, Kurt A, Elverdi T
Infect Dis Clin Microbiol. 2025; 6(4):343-348.
PMID: 39744663
PMC: 11687227.
DOI: 10.36519/idcm.2024.371.
Djenontin E, Costa J, Mousavi B, Nguyen L, Guillot J, Delhaes L
Microorganisms. 2023; 11(10).
PMID: 37894087
PMC: 10609271.
DOI: 10.3390/microorganisms11102429.
Bavadharani S, Premamalini T, Karthika K, Kindo A
J Lab Physicians. 2022; 14(4):479-484.
PMID: 36531538
PMC: 9750743.
DOI: 10.1055/s-0042-1747680.
Punia A, Choudhary P, Sharma N, Dahiya S, Gulia P, Chhillar A
Curr Drug Targets. 2022; 23(16):1465-1488.
PMID: 35748549
DOI: 10.2174/1389450123666220623164548.
Arastehfar A, Carvalho A, Houbraken J, Lombardi L, Garcia-Rubio R, Jenks J
Stud Mycol. 2021; 100:100115.
PMID: 34035866
PMC: 8131930.
DOI: 10.1016/j.simyco.2021.100115.
Azole Resistance in Clinical and Environmental s Isolates from the French West Indies (Martinique).
Monpierre L, Desbois-Nogard N, Valsecchi I, Bajal M, Angebault C, Miossec C
J Fungi (Basel). 2021; 7(5).
PMID: 33946598
PMC: 8147181.
DOI: 10.3390/jof7050355.
Physiological Responses of Aspergillus niger Challenged with Itraconazole.
Poulsen J, Madsen A, White J, Nielsen J
Antimicrob Agents Chemother. 2021; 65(6).
PMID: 33820768
PMC: 8316071.
DOI: 10.1128/AAC.02549-20.
Mechanisms of triazole resistance in Aspergillus fumigatus.
Nywening A, Rybak J, Rogers P, Fortwendel J
Environ Microbiol. 2020; 22(12):4934-4952.
PMID: 33047482
PMC: 7828461.
DOI: 10.1111/1462-2920.15274.
Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy.
Faustino C, Pinheiro L
Pharmaceutics. 2020; 12(1).
PMID: 31906268
PMC: 7023008.
DOI: 10.3390/pharmaceutics12010029.
Immunosuppressive Compounds Affect the Fungal Growth and Viability of Defined Species.
Schmidt S, Hogardt M, Demir A, Roger F, Lehrnbecher T
Pathogens. 2019; 8(4).
PMID: 31795350
PMC: 6963520.
DOI: 10.3390/pathogens8040273.
Epidemiology and Antifungal Susceptibility Profile of Species: Comparison between Environmental and Clinical Isolates from Patients with Hematologic Malignancies.
Cho S, Lee D, Kim W, Chun H, Park C, Myong J
J Clin Microbiol. 2019; 57(7).
PMID: 31018982
PMC: 6595445.
DOI: 10.1128/JCM.02023-18.
Widespread amphotericin B-resistant strains of in Hamilton, Canada.
Ashu E, Korfanty G, Samarasinghe H, Pum N, You M, Yamamura D
Infect Drug Resist. 2018; 11:1549-1555.
PMID: 30288065
PMC: 6160276.
DOI: 10.2147/IDR.S170952.
Molecular Diagnosis of Invasive Aspergillosis and Detection of Azole Resistance by a Newly Commercialized PCR Kit.
Dannaoui E, Gabriel F, Gaboyard M, Lagardere G, Audebert L, Quesne G
J Clin Microbiol. 2017; 55(11):3210-3218.
PMID: 28814586
PMC: 5654904.
DOI: 10.1128/JCM.01032-17.
Clinical implications of globally emerging azole resistance in Aspergillus fumigatus.
Meis J, Chowdhary A, Rhodes J, Fisher M, Verweij P
Philos Trans R Soc Lond B Biol Sci. 2017; 371(1709).
PMID: 28080986
PMC: 5095539.
DOI: 10.1098/rstb.2015.0460.
Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study).
Alastruey-Izquierdo A, Mellado E, Pelaez T, Peman J, Zapico S, Alvarez M
Antimicrob Agents Chemother. 2013; 57(7):3380-7.
PMID: 23669377
PMC: 3697314.
DOI: 10.1128/AAC.00383-13.
Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure.
Howard S, Cerar D, Anderson M, Albarrag A, Fisher M, Pasqualotto A
Emerg Infect Dis. 2009; 15(7):1068-76.
PMID: 19624922
PMC: 2744247.
DOI: 10.3201/eid1507.090043.
Avian Aspergillus fumigatus strains resistant to both itraconazole and voriconazole.
Beernaert L, Pasmans F, Van Waeyenberghe L, Dorrestein G, Verstappen F, Vercammen F
Antimicrob Agents Chemother. 2009; 53(5):2199-201.
PMID: 19258265
PMC: 2681513.
DOI: 10.1128/AAC.01492-08.
Clinical isolates of Aspergillus species remain fully susceptible to voriconazole in the post-voriconazole era.
Guinea J, Recio S, Pelaez T, Torres-Narbona M, Bouza E
Antimicrob Agents Chemother. 2008; 52(9):3444-6.
PMID: 18606840
PMC: 2533497.
DOI: 10.1128/AAC.00629-08.
Potential basis for amphotericin B resistance in Aspergillus terreus.
Blum G, Perkhofer S, Haas H, Schrettl M, Wurzner R, Dierich M
Antimicrob Agents Chemother. 2008; 52(4):1553-5.
PMID: 18268082
PMC: 2292529.
DOI: 10.1128/AAC.01280-07.
A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations.
Mellado E, Garcia-Effron G, Alcazar-Fuoli L, Melchers W, Verweij P, Cuenca-Estrella M
Antimicrob Agents Chemother. 2007; 51(6):1897-904.
PMID: 17371828
PMC: 1891382.
DOI: 10.1128/AAC.01092-06.